Overview Fundamentals API Earnings EOD API Sample Code Pricing

Summit Therapeutics PLC (SMMT NASDAQ) stock market data APIs

$9.53 0.41(4.5%) as of July 16, 2024
Price chart is built with Anychart

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. The company's lead development candidate is Ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis; and anti-infectives portfolio includes SMT-738, a novel class of precision antibiotics for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. and its affiliates to develop and commercialize ivonescimab. The company was founded in 2003 and is headquartered in Miami, Florida.

Summit Therapeutics PLC Financial Data Overview

9.12
9.53
-
9.78
9.06
1.52-11.25
6 728 M
25.2237
702 M
0
-0.06
-0.976
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'SMMT',
Type: 'Common Stock',
Name: 'Summit Therapeutics PLC',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00X3GQL76',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2015-03-05',
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR',
IsDelisted: false,
}

Summit Therapeutics PLC Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -114 750 000
  • Earnings Per Share 0.38
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Summit Therapeutics PLC Earnings via APIs

  • Latest Release 2024-06-14
  • EPS/Forecast -0.06

Get Summit Therapeutics PLC End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com